This summary was created by AI, based on 1 opinions in the last 12 months.
Tenet Healthcare (THC) is strategically focusing on enhancing its hospital operations while increasingly expanding its presence in ambulatory services across the U.S. The company has managed to bolster its cash reserves substantially, while also taking significant steps to reduce its debt and repurchase shares in the market. Currently, it is trading at an attractive price-to-earnings ratio of 11x, alongside a low price-to-book ratio of 3.1x, which are indicators of potential undervaluation. Furthermore, the company boasts an impressive return on equity (ROE) of 110%, showcasing efficient use of shareholder equity. Analysts suggest setting a stop-loss at $120 and aim for a price target of $173, reflecting an upside potential of approximately 25%.
Tenet Healthcare is a American stock, trading under the symbol THC-N on the New York Stock Exchange (THC). It is usually referred to as NYSE:THC or THC-N
In the last year, there was no coverage of Tenet Healthcare published on Stockchase.
Tenet Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for Tenet Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Tenet Healthcare published on Stockchase.
On 2025-04-01, Tenet Healthcare (THC-N) stock closed at a price of $133.4.
THC focuses on hospital operation and increasingly on ambulatory services across the US. It has been able to increase cash reserves, while aggressively retiring debt and buying back shares. It trades at 11x earnings, 3.1x book and supports a robust 110% ROE. We recommend setting a stop-loss at $120, looking to achieve $173 -- upside potential of 25%. Yield 0%
(Analysts’ price target is $173.53)